These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17202742)

  • 21. Surveillance of Creutzfeldt-Jakob disease.
    Commun Dis Rep CDR Wkly; 1996 Aug; 6(35):303, 306. PubMed ID: 8870343
    [No Abstract]   [Full Text] [Related]  

  • 22. Creutzfeldt-Jakob disease surveillance in Australia, update to December 2013.
    Klug GM; Boyd A; Sarros S; Stehmann C; Simpson M; McLean CA; Masters CL; Collins SJ
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E348-55. PubMed ID: 25631598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Duration of prion disease is longer in Japan than in other countries.
    Nagoshi K; Sadakane A; Nakamura Y; Yamada M; Mizusawa H
    J Epidemiol; 2011; 21(4):255-62. PubMed ID: 21628843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prion diseases with a focus on Creutzfeldt-Jakob disease, a summary of the incidence of Creutzfeldt-Jakob disease in the Czech Republic over the last 17 years, 2000-2017.
    Kolářová K; Marešová M; Manďáková Z; Kynčl J
    Epidemiol Mikrobiol Imunol; 2018; 67(4):155-160. PubMed ID: 30630318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clustering of three cases of Creutzfeldt-Jakob disease near Fukuoka City, Japan.
    Arakawa K; Nagara H; Itoyama Y; Doh-ura K; Tomokane N; Tateishi J; Goto I
    Acta Neurol Scand; 1991 Nov; 84(5):445-7. PubMed ID: 1685612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracranial Procedures and Expected Frequency of Creutzfeldt-Jakob Disease.
    Abrams JY; Maddox RA; Schonberger LB; Belay ED
    Neuroepidemiology; 2016; 46(1):1-8. PubMed ID: 26580783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relative risk of Creutzfeldt-Jakob disease with cadaveric dura transplantation in Japan.
    Nakamura Y; Aso E; Yanagawa H
    Neurology; 1999 Jul; 53(1):218-20. PubMed ID: 10408565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insight into the frequent occurrence of dura mater graft-associated Creutzfeldt-Jakob disease in Japan.
    Hamaguchi T; Sakai K; Noguchi-Shinohara M; Nozaki I; Takumi I; Sanjo N; Sadakane A; Nakamura Y; Kitamoto T; Saito N; Mizusawa H; Yamada M
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1171-5. PubMed ID: 23595947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deaths from variant Creutzfeldt-Jakob disease in the UK.
    Andrews NJ; Farrington CP; Ward HJ; Cousens SN; Smith PG; Molesworth AM; Knight RS; Ironside JW; Will RG
    Lancet; 2003 Mar; 361(9359):751-2. PubMed ID: 12620741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Creutzfeldt-Jakob disease in the Paris metropolitan area. Study of annual mortality in different density zones in relation to the age of population].
    Cathala F; Brown P; Sadowsky D
    Pathol Biol (Paris); 1984 Mar; 32(3):169-72. PubMed ID: 6371675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Creutzfeldt-Jakob disease in Slovenia from 1985 to 2003.
    Popović M; Glavac D; Smerkolj S; Svigelj V; Kalan G; Galvani V; Cernilec M; Bresjanac M
    Wien Klin Wochenschr; 2004 Aug; 116(15-16):524-9. PubMed ID: 15471179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Creutzfeldt-Jakob disease and cadaveric dura mater grafts in Japan: an updated analysis of incubation time.
    Matsui S; Sadaike T; Hamada C; Fukushima M
    Neuroepidemiology; 2005; 24(1-2):22-5. PubMed ID: 15459505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trend analysis of cancer incidence in Japan using data from selected population-based cancer registries.
    Katanoda K; Ajiki W; Matsuda T; Nishino Y; Shibata A; Fujita M; Tsukuma H; Ioka A; Soda M; Sobue T
    Cancer Sci; 2012 Feb; 103(2):360-8. PubMed ID: 22066698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ten-year mortality from Creutzfeldt-Jakob disease in Cyprus.
    Papacostas S; Malikides A; Petsa M; Kyriakides T
    East Mediterr Health J; 2008; 14(3):715-9. PubMed ID: 18720636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Creutzfeldt-Jakob disease surveillance in Australia: update to December 2015.
    Klug GM; Boyd A; Sarros S; Stehmann C; Simpson M; McLean CA; Masters CL; Collins SJ
    Commun Dis Intell Q Rep; 2016 Sep; 40(3):E368-E376. PubMed ID: 28278413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The question of clustering of Creutzfeldt-Jakob disease.
    Raubertas RF; Brown P; Cathala F; Brown I
    Am J Epidemiol; 1989 Jan; 129(1):146-54. PubMed ID: 2642649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients.
    Mills JL; Schonberger LB; Wysowski DK; Brown P; Durako SJ; Cox C; Kong F; Fradkin JE
    J Pediatr; 2004 Apr; 144(4):430-6. PubMed ID: 15069388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Creutzfeldt-Jakob disease: Australian surveillance update to December 2005.
    Klug GM; Boyd A; Lewis V; Douglass SL; Argent R; Lee JS; Masters CL; Collins SJ;
    Commun Dis Intell Q Rep; 2006; 30(1):144-7. PubMed ID: 16637244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts in Japan.
    Hoshi K; Yoshino H; Urata J; Nakamura Y; Yanagawa H; Sato T
    Neurology; 2000 Sep; 55(5):718-21. PubMed ID: 10980745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case-control study of Creutzfeldt-Jakob disease in Japan: transplantation of cadaveric dura mater was a risk factor.
    Nakamura Y; Oki I; Tanihara S; Ojima T; Yanagawa H; Kitamoto T; Sato T
    J Epidemiol; 2000 Nov; 10(6):399-402. PubMed ID: 11210109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.